Coronary Artery Disease
High-risk percutaneous coronary intervention: How far will 6-Fr take you?†
First published: 19 May 2011
No abstract is available for this article.
REFERENCES
- 1
Takahashi A,Taniguchi N.
Supported percutaneous coronary intervention using a novel 6-Fr intra-aortic balloon pump catheter via the brachial artery in a nonagenarian patient with an abdominal aortic aneurysm.
Catheter Cardiovasc Interv 2011;DOI 10.1002/ccd.22898.
- 2
O'Neill W.
“PROTECT II: A prospective, multicenter, randomized clinical trial of intra-aortic balloon pump versus Impella for hemodynamic support during high-risk PCI.”
Presented at the 60th Annual Scientific Sessions and I2 Summit. New Orleans, Louisiana.
- 3
Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW.
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
Eur Heart J
2009;
30:
2102–2108.
- 4
Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S; BCIS-1 Investigators.
Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
JAMA
2010;
304:
867–874.
- 5
Antman EM,Anbe DT,Armstrong PW,Bates ER,Green LA,Hand M,Hochman JS,Krumholz HM,Kushner FG,Lamas GA,Mullany CJ,Ornato JP,Pearle DL,Sloan MA,Smith SCJr.
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction.
J Am Coll Cardiol
2004;
44:
671–719.
